Cargando…

Ceftriaxone/cobicistat/darunavir/hydroxychloroquine: Off-label use and lack of efficacy: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795301/ http://dx.doi.org/10.1007/s40278-022-09344-6

Ejemplares similares

Cobicistat/darunavir/cobicistat/darunavir/emtricitabine/tenofovir-alafenamide/darunavir/ritonavir: Various toxicities and off-label use: 9 case reports
Publicado: (2020)

Ceftriaxone/hydroxychloroquine/lopinavir: Lack of efficacy in off-label use: case report
Publicado: (2021)

Ceftriaxone/heparin/hydroxychloroquine: Thrombocytopenia and off-label use: case report
Publicado: (2020)

Ceftriaxone/favipiravir/vancomycin: Lack of efficacy and off-label use: case report
Publicado: (2022)

Caspofungin/ceftriaxone/hydroxychloroquine: Brugada syndrome and off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Lack of efficacy following an off-label use: case report
Publicado: (2021)

Ceftriaxone/dexamethasone/levofloxacin: Lack of efficacy following off-label use: case report
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Lack of efficacy during off label use treatment: case report
Publicado: (2021)

Hydroxychloroquine/lopinavir/ritonavir: Lack of efficacy and off label use: 3 case reports
Publicado: (2022)

Hydroxychloroquine/lopinavir/ritonavir: Lack of efficacy following off-label use: case report
Publicado: (2022)

Ceftriaxone/doxycycline/immunosuppressants: Disseminated histoplasmosis following an off label use and lack of efficacy: case report
Publicado: (2022)

Azithromycin/ceftriaxone/remdesivir: Bradycardia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report
Publicado: (2020)

Azithromycin/eculizumab/hydroxychloroquine: Normocytic anaemia, lack of efficacy and off-label use: case report
Publicado: (2022)

Hydroxychloroquine/lopinavir/ritonavir/tocilizumab: Lack of efficacy following off label use: case report
Publicado: (2022)

Ceftriaxone: Lack of efficacy: case report
Publicado: (2022)

Epoprostenol/hydroxychloroquine/tocilizumab: Acute large bowel perforation, off-label use and lack of efficacy: case report
Publicado: (2020)

Ceftriaxone: Cholelithiasis following off-label use: case report
Publicado: (2021)

Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations
por: Gutierrez‐Valencia, Alicia, et al.
Publicado: (2018)

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
por: Marin, Ruxandra-Cristina, et al.
Publicado: (2021)

Antibacterials/convalescent-anti-SARS-CoV-2-plasma/hydroxychloroquine: Off-label use and lack of efficacy: case report
Publicado: (2022)

Azithromycin/enoxaparin sodium/hydroxychloroquine: Gastrointestinal bleeding, ischaemic stroke due to off-label use, and lack of efficacy: case report
Publicado: (2021)

Ceftriaxone/dopamine/vancomycin: Lack of efficacy: case report
Publicado: (2021)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)

Azithromycin: Lack of efficacy and off-label use: case report
Publicado: (2021)

Baricitinib/ceftriaxone/metoclopramide: Extrapyramidal syndrome and off label use: case report
Publicado: (2021)

Ceftriaxone/dexamethasone/immune-globulin: Hyperglycaemia and Off-label-use: case report
Publicado: (2021)

Azithromycin/ceftriaxone/hydroxychloroquine: Acute urticaria: case report
Publicado: (2020)

Hydroxychloroquine: Rash following off label use: case report
Publicado: (2020)

Hydroxychloroquine: Haemolysis following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Eosinophilia following off-label use: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Off label use and lack of efficacy: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy and off-label use: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy and off label use: case report
Publicado: (2022)

Remdesivir/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy and off-label use: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jfhri0g0a496ev6519e0kbsogt